Efficacy of SGLT2 Inhibitors in Reducing Hospitalization for Heart Failure in Patients with Type 2 Diabetes: A Meta-Analysis. (2025). Vascular and Endovascular Review, 8(1s), 47-52. https://verjournal.com/index.php/ver/article/view/97